DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 2DR. REDDY'S LABORATORIES LIMITED Hyderabad IN
02 1TEVA PHARMACEUTICAL INDUSTRIES LTD Tel Aviv - Jaffa IL
03 1AUROBINDO PHARMA LIMITED Hyderabad IN
04 1Albemarle Corporation Orangeburg US
05 1CORDEN PHARMA BERGAMO S.P.A. Treviglio IT
06 1DIVI'S LABORATORIES LIMITED Hyderabad IN
07 1HY-GRO CHEMICALS PHARMTEK PRIVATE LIMITED Secunderabad IN
08 1MYLAN LABORATORIES LIMITED Hyderabad IN
09 1Pharmacin B.V. Zwijndrecht NL
10 1Zambon Group SpA Lonigo IT
11 1Zhejiang Charioteer Pharmaceutical Co., Ltd. Xianju CN
01 12Naproxen
01 1China
02 5India
03 1Israel
04 2Italy
05 1Netherlands
06 2U.S.A
01 1Expired
02 7Valid
03 4Withdrawn by Holder
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Certificate Number : R1-CEP 1999-128 - Rev 07
Status : Valid
Issue Date : 2020-07-17
Type : Chemical
Substance Number : 731
Certificate Number : R1-CEP 1997-064 - Rev 08
Status : Valid
Issue Date : 2022-03-24
Type : Chemical
Substance Number : 731
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Certificate Number : R1-CEP 1997-039 - Rev 07
Status : Valid
Issue Date : 2019-06-21
Type : Chemical
Substance Number : 731
Certificate Number : R1-CEP 1997-050 - Rev 03
Status : Withdrawn by Holder
Issue Date : 2008-08-14
Type : Chemical
Substance Number : 731
Certificate Number : R1-CEP 2008-305 - Rev 01
Status : Valid
Issue Date : 2015-09-04
Type : Chemical
Substance Number : 731
Certificate Number : R1-CEP 2006-270 - Rev 02
Status : Valid
Issue Date : 2018-03-12
Type : Chemical
Substance Number : 731
Certificate Number : R1-CEP 1996-081 - Rev 07
Status : Withdrawn by Holder
Issue Date : 2018-05-17
Type : Chemical
Substance Number : 731
Certificate Number : R1-CEP 1999-042 - Rev 08
Status : Valid
Issue Date : 2018-02-28
Type : Chemical
Substance Number : 731
Certificate Number : CEP 2022-412 - Rev 00
Status : Valid
Issue Date : 2024-11-26
Type : Chemical
Substance Number : 731
Certificate Number : R1-CEP 1999-008 - Rev 06
Status : Withdrawn by Holder
Issue Date : 2017-09-25
Type : Chemical
Substance Number : 731
A Naproxen manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Naproxen, including repackagers and relabelers. The FDA regulates Naproxen manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Naproxen API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Naproxen manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Naproxen supplier is an individual or a company that provides Naproxen active pharmaceutical ingredient (API) or Naproxen finished formulations upon request. The Naproxen suppliers may include Naproxen API manufacturers, exporters, distributors and traders.
click here to find a list of Naproxen suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Naproxen CEP of the European Pharmacopoeia monograph is often referred to as a Naproxen Certificate of Suitability (COS). The purpose of a Naproxen CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Naproxen EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Naproxen to their clients by showing that a Naproxen CEP has been issued for it. The manufacturer submits a Naproxen CEP (COS) as part of the market authorization procedure, and it takes on the role of a Naproxen CEP holder for the record. Additionally, the data presented in the Naproxen CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Naproxen DMF.
A Naproxen CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Naproxen CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Naproxen suppliers with CEP (COS) on PharmaCompass.
We have 11 companies offering Naproxen
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?